インフルエンザ診断の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21APR3166)
◆英語タイトル:Global Influenza Diagnostics Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR3166
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年4月
◆ページ数:96
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥499,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥748,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、インフルエンザ診断の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(RIDT、RT-PCR、細胞培養、その他)、用途別市場規模(病院、POCT、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・インフルエンザ診断の市場動向
・企業の競争状況、市場シェア
・インフルエンザ診断の種類別市場規模(RIDT、RT-PCR、細胞培養、その他)
・インフルエンザ診断の用途別市場規模(病院、POCT、その他)
・インフルエンザ診断の北米市場規模2016-2027(アメリカ、カナダ)
・インフルエンザ診断の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・インフルエンザ診断のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・インフルエンザ診断の中南米市場規模2016-2027(メキシコ、ブラジル)
・インフルエンザ診断の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(BD、Abbott (Include Alere)、Roche、SIEMENS、Analytik Jena、Quidel、Thermo Fisher、Meridian Bioscience、BioMerieux、Sekisui Diagnostics、Response Biomedical、SA Scientific)
・結論
【レポートの概要】

Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).
The major producers in this industry are BD, Abbott (Include Alere) and Roche, whose combined revenue ratio in 2019 is 50.61%.

Market Analysis and Insights: Global Influenza Diagnostics Market
The global Influenza Diagnostics market size is projected to reach US$ 3174.9 million by 2026, from US$ 2055.4 million in 2019, at a CAGR of 6.3% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Influenza Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Influenza Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Influenza Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Influenza Diagnostics market.

Global Influenza Diagnostics Scope and Market Size
Influenza Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
RIDT
RT-PCR
Cell Culture
Others

Segment by Application
Hospitals
POCT
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
SIEMENS

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Influenza Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 RIDT
1.2.3 RT-PCR
1.2.4 Cell Culture
1.2.5 Others
1.3 Market by Application
1.3.1 Global Influenza Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 POCT
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Influenza Diagnostics Market Perspective (2016-2027)
2.2 Influenza Diagnostics Growth Trends by Regions
2.2.1 Influenza Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Influenza Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Influenza Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Influenza Diagnostics Industry Dynamic
2.3.1 Influenza Diagnostics Market Trends
2.3.2 Influenza Diagnostics Market Drivers
2.3.3 Influenza Diagnostics Market Challenges
2.3.4 Influenza Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Influenza Diagnostics Players by Revenue
3.1.1 Global Top Influenza Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Influenza Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Influenza Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Influenza Diagnostics Revenue
3.4 Global Influenza Diagnostics Market Concentration Ratio
3.4.1 Global Influenza Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Influenza Diagnostics Revenue in 2020
3.5 Influenza Diagnostics Key Players Head office and Area Served
3.6 Key Players Influenza Diagnostics Product Solution and Service
3.7 Date of Enter into Influenza Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Influenza Diagnostics Breakdown Data by Type
4.1 Global Influenza Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Influenza Diagnostics Forecasted Market Size by Type (2022-2027)

5 Influenza Diagnostics Breakdown Data by Application
5.1 Global Influenza Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Influenza Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Influenza Diagnostics Market Size (2016-2027)
6.2 North America Influenza Diagnostics Market Size by Type
6.2.1 North America Influenza Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Influenza Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Influenza Diagnostics Market Size by Type (2016-2027)
6.3 North America Influenza Diagnostics Market Size by Application
6.3.1 North America Influenza Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Influenza Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Influenza Diagnostics Market Size by Application (2016-2027)
6.4 North America Influenza Diagnostics Market Size by Country
6.4.1 North America Influenza Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Influenza Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Influenza Diagnostics Market Size (2016-2027)
7.2 Europe Influenza Diagnostics Market Size by Type
7.2.1 Europe Influenza Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Influenza Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Influenza Diagnostics Market Size by Type (2016-2027)
7.3 Europe Influenza Diagnostics Market Size by Application
7.3.1 Europe Influenza Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Influenza Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Influenza Diagnostics Market Size by Application (2016-2027)
7.4 Europe Influenza Diagnostics Market Size by Country
7.4.1 Europe Influenza Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Influenza Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Influenza Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Influenza Diagnostics Market Size by Type
8.2.1 Asia-Pacific Influenza Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Influenza Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Influenza Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Influenza Diagnostics Market Size by Application
8.3.1 Asia-Pacific Influenza Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Influenza Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Influenza Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Influenza Diagnostics Market Size by Region
8.4.1 Asia-Pacific Influenza Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Influenza Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Influenza Diagnostics Market Size (2016-2027)
9.2 Latin America Influenza Diagnostics Market Size by Type
9.2.1 Latin America Influenza Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Influenza Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Influenza Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Influenza Diagnostics Market Size by Application
9.3.1 Latin America Influenza Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Influenza Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Influenza Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Influenza Diagnostics Market Size by Country
9.4.1 Latin America Influenza Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Influenza Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Influenza Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Influenza Diagnostics Market Size by Type
10.2.1 Middle East & Africa Influenza Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Influenza Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Influenza Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Influenza Diagnostics Market Size by Application
10.3.1 Middle East & Africa Influenza Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Influenza Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Influenza Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Influenza Diagnostics Market Size by Country
10.4.1 Middle East & Africa Influenza Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Influenza Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 BD
11.1.1 BD Company Details
11.1.2 BD Business Overview
11.1.3 BD Influenza Diagnostics Introduction
11.1.4 BD Revenue in Influenza Diagnostics Business (2016-2021)
11.1.5 BD Recent Development
11.2 Abbott (Include Alere)
11.2.1 Abbott (Include Alere) Company Details
11.2.2 Abbott (Include Alere) Business Overview
11.2.3 Abbott (Include Alere) Influenza Diagnostics Introduction
11.2.4 Abbott (Include Alere) Revenue in Influenza Diagnostics Business (2016-2021)
11.2.5 Abbott (Include Alere) Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Influenza Diagnostics Introduction
11.3.4 Roche Revenue in Influenza Diagnostics Business (2016-2021)
11.3.5 Roche Recent Development
11.4 SIEMENS
11.4.1 SIEMENS Company Details
11.4.2 SIEMENS Business Overview
11.4.3 SIEMENS Influenza Diagnostics Introduction
11.4.4 SIEMENS Revenue in Influenza Diagnostics Business (2016-2021)
11.4.5 SIEMENS Recent Development
11.5 Analytik Jena
11.5.1 Analytik Jena Company Details
11.5.2 Analytik Jena Business Overview
11.5.3 Analytik Jena Influenza Diagnostics Introduction
11.5.4 Analytik Jena Revenue in Influenza Diagnostics Business (2016-2021)
11.5.5 Analytik Jena Recent Development
11.6 Quidel
11.6.1 Quidel Company Details
11.6.2 Quidel Business Overview
11.6.3 Quidel Influenza Diagnostics Introduction
11.6.4 Quidel Revenue in Influenza Diagnostics Business (2016-2021)
11.6.5 Quidel Recent Development
11.7 Thermo Fisher
11.7.1 Thermo Fisher Company Details
11.7.2 Thermo Fisher Business Overview
11.7.3 Thermo Fisher Influenza Diagnostics Introduction
11.7.4 Thermo Fisher Revenue in Influenza Diagnostics Business (2016-2021)
11.7.5 Thermo Fisher Recent Development
11.8 Meridian Bioscience
11.8.1 Meridian Bioscience Company Details
11.8.2 Meridian Bioscience Business Overview
11.8.3 Meridian Bioscience Influenza Diagnostics Introduction
11.8.4 Meridian Bioscience Revenue in Influenza Diagnostics Business (2016-2021)
11.8.5 Meridian Bioscience Recent Development
11.9 BioMerieux
11.9.1 BioMerieux Company Details
11.9.2 BioMerieux Business Overview
11.9.3 BioMerieux Influenza Diagnostics Introduction
11.9.4 BioMerieux Revenue in Influenza Diagnostics Business (2016-2021)
11.9.5 BioMerieux Recent Development
11.10 Sekisui Diagnostics
11.10.1 Sekisui Diagnostics Company Details
11.10.2 Sekisui Diagnostics Business Overview
11.10.3 Sekisui Diagnostics Influenza Diagnostics Introduction
11.10.4 Sekisui Diagnostics Revenue in Influenza Diagnostics Business (2016-2021)
11.10.5 Sekisui Diagnostics Recent Development
11.11 Response Biomedical
11.11.1 Response Biomedical Company Details
11.11.2 Response Biomedical Business Overview
11.11.3 Response Biomedical Influenza Diagnostics Introduction
11.11.4 Response Biomedical Revenue in Influenza Diagnostics Business (2016-2021)
11.11.5 Response Biomedical Recent Development
11.12 SA Scientific
11.12.1 SA Scientific Company Details
11.12.2 SA Scientific Business Overview
11.12.3 SA Scientific Influenza Diagnostics Introduction
11.12.4 SA Scientific Revenue in Influenza Diagnostics Business (2016-2021)
11.12.5 SA Scientific Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ インフルエンザ診断の世界市場規模・現状・予測2021年-2027年(Global Influenza Diagnostics Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。